• S1EP11 Fenbendazole and Cancer: Unveiling the Truth Behind the Controversy

  • Nov 24 2023
  • Length: 4 mins
  • Podcast

S1EP11 Fenbendazole and Cancer: Unveiling the Truth Behind the Controversy

Listen for free

View show details

  • Summary

  • Got Questions? Send us a message!

    Dive into a nuanced discussion on "Fenben Voices" about Fenbendazole's journey from a veterinary dewormer to its debated role in cancer therapy. This episode untangles the web of scientific studies, personal testimonies, and controversies to offer a comprehensive look at:

    • Fenbendazole’s deworming roots and microtubule connection.
    • The cautious optimism from preliminary research and the push for clinical trials.
    • The skepticism from lack of rigorous studies and regulatory hurdles.
    • Personal narratives and the ethical implications of self-experimentation.
      Join us as we explore the complexities of Fenbendazole in cancer treatment, aiming to empower listeners with informed insights.

    FenbendazoleHelp.org is an informational resource provided by the Fenben Foundation. The Fenben Foundation and its informational resources are not intended to provide personal medical advice. Always consult your physician before beginning any protocols. No information on this site is intended to diagnose, treat, or otherwise replace the opinion of medical professionals. The purpose of this site is for informational purposes ONLY.
    Show More Show Less
Show More Show Less

What listeners say about S1EP11 Fenbendazole and Cancer: Unveiling the Truth Behind the Controversy

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com.au reviews

Amazon Reviews
No Reviews are Available
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.